Legal Notice
Company Information
Company Name: Zypharaloxe
Legal Form: Private Limited Company
Company Registration: 63436876
VAT Registration: GB086642856
Companies House Registration: England and Wales
Registered Office Address
20 Colmore Circus Queensway, Birmingham B4 6AT, United Kingdom
Company Management
Managing Director: Sarah Mitchell
Chief Executive Officer: Sarah Mitchell
Board of Directors: Sarah Mitchell, David Thompson
Contact Details
Phone: +44 7911 2873 9711
Email: contact@zypharaloxe.com
Website: zypharaloxe.com
Business Hours: Monday to Friday, 9:00 AM to 5:00 PM GMT
Regulatory Information
Authorised and regulated by the Financial Conduct Authority (FCA) FRN 598016
Regulatory Authority: Financial Conduct Authority (FCA)
FCA Reference Number: 598016
Professional Body: Chartered Institute for Securities & Investment
Professional Indemnity Insurance
Insurance Provider: Lloyd's of London Syndicate
Policy Number: PI/2025/455356
Coverage Territory: United Kingdom and European Union
Insurer Address: One Lime Street, London EC3M 7HA
Online Dispute Resolution
We are committed to resolving any disputes fairly and efficiently
EU residents can access the European Commission's Online Dispute Resolution platform at ec.europa.eu/consumers/odr
https://ec.europa.eu/consumers/odr
For dispute resolution enquiries, contact info@zypharaloxe.com: contact@zypharaloxe.com
Content Responsibility
All content on this website is the responsibility of Zypharaloxe and is subject to UK law
Editorial Responsibility: Sarah Mitchell, Managing Director
Copyright Notice
2025 Zypharaloxe. All rights reserved.
All content, trademarks, and intellectual property on this website are owned by Zypharaloxe unless otherwise stated
Legal Disclaimer
This legal notice complies with UK company law and FCA requirements for financial services websites
To the fullest extent permitted by law, we exclude all liability for any loss or damage arising from your use of this website or reliance on any information provided herein.
Last updated: August 9, 2025